• by Bruce Carlson
  • October 26 2018


Despite Gains Over Malaria Infections, Diagnostics Need Still Growing

Deaths from malaria have fallen steadily worldwide over the past 20 years due to intensive global investment in malaria prevention and treatment. The malaria mortality rate fell by 60 percent from 2000 to 2015 worldwide, while the incidence is estimated to have decreased by 37%, according to the World Health Organization (WHO).


Artificial Intelligence, One Day, Can Keep the Doctor Away

Artificial Intelligence, One Day, Can Keep the Doctor Away

Diagnosis by computer has long been a staple of science fiction, but fiction is rapidly becoming reality, with companies like Babylon Health and Ada Health developing artificial intelligence-based diagnostics that can be accessed by anyone with a smartphone. Some even claim that AI can outperform human physicians, which leads one to ask: will our doctors be replaced by robots?

  • by Bruce Carlson
  • October 23 2018


$11 Billion Market for Downstream Bioprocessing

Our latest market study, Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors), has found that the downstream bioprocessing market reached $11 billion in 2017


CVS-Aetna Merger and Walgreens-LabCorp Partnership: Assessing The Impact

CVS-Aetna Merger and Walgreens-LabCorp Partnership: Assessing The Impact

The two largest pharmacy chains both made very big competitive moves in the same month. CVS merged with healthcare insurance provider Aetna. Walgreens partnered with LabCorp. Both events are a good sign for the market for in vitro diagnostics, as we explain in this article.

  • by Bruce Carlson
  • October 16 2018
  • EMR


Moving the Ball Forward on EMR Connectivity for IVD Devices

Moving the Ball Forward on EMR Connectivity for IVD Devices

An interview with Serge Jonnaert, president of the IVD Industry Connectivity Consortium, by Kalorama correspondent Julie Kirkwood.


Next Generation Sequencing Continues to Make Strides: Neonatal Screening, Onco-genomics, Infectious Disease Dx, and More

Next Generation Sequencing Continues to Make Strides: Neonatal Screening, Onco-genomics, Infectious Disease Dx, and More

A quick look into some of the latest developments in the next generation sequencing segment, announced since the publication of the latest edition of our IVD report.